Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea.


Journal

Respiratory physiology & neurobiology
ISSN: 1878-1519
Titre abrégé: Respir Physiol Neurobiol
Pays: Netherlands
ID NLM: 101140022

Informations de publication

Date de publication:
06 2021
Historique:
received: 23 12 2020
revised: 03 02 2021
accepted: 24 02 2021
pubmed: 2 3 2021
medline: 13 4 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

The purpose of this study was to examine the physiological mechanisms of persistent dyspnoea in COVID-19 survivors. Non-critical patients (n = 186) with varying degrees of COVID-19 severity reported persistent symptoms using a standardized questionnaire and underwent pulmonary function and 6-minute walk testing between 30 and 90 days following the onset of acute COVID-19 symptoms. Patients were divided into those with (n = 70) and without (n = 116) persistent dyspnoea. Patients with persistent dyspnoea had significantly lower FVC (p = 0.03), FEV

Identifiants

pubmed: 33647535
pii: S1569-9048(21)00029-X
doi: 10.1016/j.resp.2021.103644
pmc: PMC7910142
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103644

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

JAMA Netw Open. 2020 Dec 1;3(12):e2026881
pubmed: 33275153
Am J Respir Crit Care Med. 2016 Feb 1;193(3):299-309
pubmed: 26407036
J Aging Health. 2020 Aug-Sep;32(7-8):543-553
pubmed: 30913945
Eur Respir J. 2005 Oct;26(4):720-35
pubmed: 16204605
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Eur Respir J. 2021 Mar 4;57(3):
pubmed: 32732325
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Eur Respir J. 2017 Sep 11;50(3):
pubmed: 28893868
Clin Med (Lond). 2009 Oct;9(5):448-52
pubmed: 19886106
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
Eur Respir J. 2020 Nov 26;56(5):
pubmed: 33008936
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7
pubmed: 9817683
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Ann Intern Med. 2021 Mar;174(3):362-373
pubmed: 33253040
Eur Respir J. 2014 Jun;43(6):1750-62
pubmed: 24525437
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882

Auteurs

Arturo Cortés-Telles (A)

Respiratory and Thoracic Surgery Unit. Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Calle 7 por 20 y 22 Num. 433, Fraccionamiento Altabrisa, Mérida, Yucatán, 97130, Mexico. Electronic address: dr_morenheim@hotmail.com.

Stephanie López-Romero (S)

Internal Medicine Department. Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Calle 7 por 20 y 22 Num. 433, Fraccionamiento Altabrisa, Mérida, Yucatán, 97130, Mexico.

Esperanza Figueroa-Hurtado (E)

Respiratory and Thoracic Surgery Unit. Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Calle 7 por 20 y 22 Num. 433, Fraccionamiento Altabrisa, Mérida, Yucatán, 97130, Mexico.

Yuri Noemi Pou-Aguilar (YN)

Respiratory and Thoracic Surgery Unit. Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Calle 7 por 20 y 22 Num. 433, Fraccionamiento Altabrisa, Mérida, Yucatán, 97130, Mexico.

Alyson W Wong (AW)

Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, British Columbia, V5Z 1M9, Canada; Centre for Heart Lung Innovation, Providence Health Care Research Institute, The University of British Columbia and St. Paul's Hospital, 166-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada.

Kathryn M Milne (KM)

Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, British Columbia, V5Z 1M9, Canada; Centre for Heart Lung Innovation, Providence Health Care Research Institute, The University of British Columbia and St. Paul's Hospital, 166-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada.

Christopher J Ryerson (CJ)

Department of Medicine, The University of British Columbia, 2775 Laurel Street, Vancouver, British Columbia, V5Z 1M9, Canada; Centre for Heart Lung Innovation, Providence Health Care Research Institute, The University of British Columbia and St. Paul's Hospital, 166-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada.

Jordan A Guenette (JA)

Centre for Heart Lung Innovation, Providence Health Care Research Institute, The University of British Columbia and St. Paul's Hospital, 166-1081 Burrard Street, Vancouver, British Columbia, V6Z 1Y6, Canada; Department of Physical Therapy, The University of British Columbia, 2177 Wesbrook Mall, Vancouver, British Columbia, V6T 1Z3, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH